KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha

被引:127
作者
Jiang, Y
Berk, M
Singh, LS
Tan, HY
Yin, LH
Powell, CT
Xu, Y
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Gynecol & Obstet, Cleveland, OH 44195 USA
[3] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA
关键词
in vivo mouse model; KiSS1; lysophosphatidic acid (LPA); metastasis; ovarian cancer; protein kinase C (PKC);
D O I
10.1007/s10585-005-8186-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is a vital target for cancer treatment, since the majority of cancer patients die from metastatic, rather than the primary disease. KiSS1 has been identified as a metastasis suppressor gene in melanoma and breast carcinomas. We show here that KiSS1 is also a metastasis suppressor in human ovarian cancer. Overexpression of KiSS1 in ovarian cancer cells inhibits cell migration induced by serum or lysophosphatidic acid (LPA), and colonization in soft agar, but not cell proliferation, representing the characteristics of a metastasis suppressor gene. Furthermore, using an experimental metastatic mouse model, we show that expression of KiSS1 in SKOV3 ovarian cancer cells suppresses > 50% metastatic colonization in mice (P < 0.0001). We find that activating protein kinase C (PKC) reverses about 80% of the inhibited cell migration induced by KiSS1, while down-regulation of PKC alpha with shRNA restores KiSS1 effect, providing evidence that inhibiting PKC alpha may be an important mechanism of the effect of KiSS1. These results suggest that KiSS1 is a metastasis suppressor of ovarian cancer and may be a potential molecular target for the treatment.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 38 条
  • [1] Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific
    Baudhuin, LM
    Cristina, KL
    Lu, J
    Xu, Y
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (03) : 660 - 671
  • [2] Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
    de Roux, N
    Genin, E
    Carel, JC
    Matsuda, F
    Chaussain, JL
    Milgrom, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10972 - 10976
  • [3] Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and θ
    Gill, PK
    Gescher, A
    Gant, TW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (15): : 4151 - 4157
  • [4] Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate
    Goldberg, SF
    Harms, JF
    Quon, K
    Welch, DR
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (07) : 601 - 607
  • [5] KISS1 metastasis suppression and emergent pathways
    Harms, JF
    Welch, DR
    Miele, ME
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) : 11 - 18
  • [6] Dramatic elevation of plasma metastin concentrations in human pregnancy: Metastin as a novel placenta-derived hormone in humans
    Horikoshi, Y
    Matsumoto, H
    Takatsu, Y
    Ohtaki, T
    Kitada, C
    Usuki, S
    Fujino, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 914 - 919
  • [7] Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma
    Ikeguchi, M
    Hirooka, Y
    Kaibara, N
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (09) : 531 - 535
  • [8] Transcriptional expression of genes involved in cell invasion and migration by norn and tumoral trophoblast cells
    Janneau, JL
    Maldonado-Estrada, J
    Tachdjian, G
    Miran, I
    Motte, N
    Saulnier, P
    Sabourin, JC
    Coté, JF
    Simon, B
    Frydman, R
    Chaouat, G
    Bellet, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) : 5336 - 5339
  • [9] Cancer statistics, 2003
    Jemal, A
    Murray, T
    Samuels, A
    Ghafoor, A
    Ward, E
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2003, 53 (01) : 5 - 26
  • [10] JOHANN H, 2004, CURR CANCER DRUG TAR, V4, P125